过去一年中添加的文章,按日期排序

FLT3-selective PROTAC: Enhanced safety and increased synergy with Venetoclax in FLT3-ITD mutated acute myeloid leukemia

Y Tan, L Xin, Q Wang, R Xu, X Tong, G Chen, L Ma… - Cancer letters, 2024 - Elsevier
42 天前 - … better anti-tumor effects, lower platelet toxicity, and lower hepatic toxicity in FLT3-ITD
+ … The FLT3-selective PROTAC can mitigate the platelet toxicity of small molecule inhibitors

FLT3-ITD-Specific PROTAC:: Enhanced Safety and Increased Synergy with Venetoclax in Acute Myeloid Leukemia

Y Tan, L Xin, Q Wang, R Xu, X Tong, G Chen, L Ma… - 2023 - papers.ssrn.com
192 天前 - … showed better anti-tumor effects, lower platelet 39 … has a more specific targeting
ability, less platelet and liver toxicity, 67 … the platelet toxicity of small molecule inhibitors and 72 …